Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims & Hers Health, Inc. (NYSE: HIMS) focus
Hims & Hers: Here are the risks with the stock after Novo Nordisk terminated its partnership
03:36pm, Tuesday, 24'th Jun 2025
Herb Greenberg, 'Herb on the Street' author, joins 'Power Lunch' to discuss Greenberg's thoughts on the terminated partnership between Novo Nordisk and Hims & Hers.
Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact
02:50pm, Tuesday, 24'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of fe
HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?
01:30pm, Tuesday, 24'th Jun 2025
Telehealth darling Hims & Hers Health Inc HIMS got slapped with a 34% stock crash on Monday. Novo Nordisk A/S NVO ended their relationship – and it wasn't amicable.
Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care
12:50pm, Tuesday, 24'th Jun 2025
HIMS expands its weight loss platform with a bundled Wegovy program and tech-driven obesity care solutions.
Hims & Hers: The Novo Nordisk Breakup Changes Nothing
10:02am, Tuesday, 24'th Jun 2025
The Novo Nordisk partnership ending does not alter my long-term bullish thesis on HIMS; the company is much more than just a GLP-1 play. HIMS' core value lies in its broad treatment offerings and disr
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Hims & Hers Health, Inc.
Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff' Wegovy
08:31am, Tuesday, 24'th Jun 2025
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims & Hers Health (NYSE: HIMS), citing concerns over Hims & Hers'
Why Hims & Hers Stock Could Be a Multi-Bagger in the Making
08:24am, Tuesday, 24'th Jun 2025
It's not often that investors come across the kind of companies that can yield a multi-bagger investment over the years. Still, today, there is one name that possesses all the right components (and ti
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the
Why Did Hims and Hers Stock Crash on Monday?
06:30am, Tuesday, 24'th Jun 2025
In this video, I will explain why Hims & Hers Health (HIMS -34.62%) crashed over 30% on Monday. Watch the short video to learn more, consider subscribing, and click the special offer link below.
HIMS Stock To $25?
05:35am, Tuesday, 24'th Jun 2025
Hims & Hers Health (NASDAQ: HIMS) experienced a devastating 35% stock crash on June 23, 2025, after Novo Nordisk abruptly terminated their brief partnership. The dramatic sell-off reflects not just th
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
11:55pm, Monday, 23'rd Jun 2025
LOS ANGELES , June 23, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIM
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm
07:41pm, Monday, 23'rd Jun 2025
LOS ANGELES--(BUSINESS WIRE)---- $HIMS--HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm.
SAN DIEGO , June 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Hims & Hers Health, Inc. (NYSE: HIMS) focused
